{"SPADE_UN_11007": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2011/0159022 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2011_0159022_A1", "Patent Type": "Patent Application", "Publication Date": "2011-6-30", "Family Info": "CA2728459A1,CN102123731A,EP2296697A1,WO2009153463A1", "Patent Title": "Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine.", "Abstract": "A peptide derived from the Midkine protein, comprising at least one CD4+ T or CD8+ T epitope restricted by the HLA molecules predominant in the Caucasian population, or a polynucleotide encoding said peptide, as an anticancer vaccine or as a reagent for immunomonitoring of the cellular response against Midkine over the course of a cancer or of an anticancer treatment."}], "Sequence Information": {"SPADE ID": "SPADE_UN_11007", "Sequence": "EAEQLRAYLDGTGVE", "Sequence Length": 15, "Peptide Name": "Sequence 32 from Patent US 20110159022", "Source": "Synthetic construct", "Biological Activity": ["Anticancer"], "Frequent Amino Acids": "EAG", "Absent Amino Acids": "CFHIKMNOPSUW", "Basic Residues": 1, "Acidic Residues": 4, "Hydrophobic Residues": 6, "Polar Residues": 7, "Positive Residues": 1, "Negative Residues": 4, "Mass": 1650.74, "PI": 4.24, "Net Charge": -3, "Hydrophobicity": -0.63, "Similar Sequences": [{"SPADE_ID": "SPADE_N_03982", "Similarity": 0.75, "Sequence": "EAEPEAEP"}, {"SPADE_ID": "SPADE_N_03985", "Similarity": 0.75, "Sequence": "EAESEAEP"}, {"SPADE_ID": "SPADE_N_03986", "Similarity": 0.75, "Sequence": "EAELEAEP"}]}}}